Jeffrey Bacha - Net Worth and Insider Trading
Jeffrey Bacha Net Worth
The estimated net worth of Jeffrey Bacha is at least $154,943 dollars as of 2024-09-20. Jeffrey Bacha is the Senior Officer of Rakovina Therapeutics Inc and owns about 1,822,857 shares of Rakovina Therapeutics Inc (TSXV:RKV) stock worth over $154,943. Details can be seen in Jeffrey Bacha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey Bacha has not made any transactions after 2024-04-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey Bacha
Jeffrey Bacha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Bacha owns 2 companies in total, including Rakovina Therapeutics Inc (TSXV:RKV) , and Sernova Corp (TSX:SVA) .
Click here to see the complete history of Jeffrey Bacha’s form 4 insider trades.
Insider Ownership Summary of Jeffrey Bacha
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:RKV | Rakovina Therapeutics Inc | 2024-04-19 | Senior Officer |
| TSX:SVA | Sernova Corp | 2011-02-04 | Director |
Jeffrey Bacha Latest Holdings Summary
Jeffrey Bacha currently owns a total of 1 stock. Jeffrey Bacha owns 1,822,857 shares of Rakovina Therapeutics Inc (TSXV:RKV) as of April 19, 2024, with a value of $154,943.
Latest Holdings of Jeffrey Bacha
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:RKV | Rakovina Therapeutics Inc | 2024-04-19 | 1,822,857 | 0.09 | 154,943 |
Holding Weightings of Jeffrey Bacha
Jeffrey Bacha Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey Bacha has made a total of 5 transactions in Rakovina Therapeutics Inc (TSXV:RKV) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Rakovina Therapeutics Inc is the acquisition of 25,000 shares on April 19, 2024, which cost Jeffrey Bacha around $2,375.
Insider Trading History of Jeffrey Bacha
- 1
Jeffrey Bacha Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey Bacha's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Bacha is 8.72%. GuruFocus also compares Jeffrey Bacha's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Bacha within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey Bacha's insider trading performs compared to the benchmark.
Performance of Jeffrey Bacha
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.78 | | | | | |
| Relative Return to S&P 500(%) | 4.44 | | | | | |
Jeffrey Bacha Ownership Network
Jeffrey Bacha Owned Company Details
What does Rakovina Therapeutics Inc do?
Who are the key executives at Rakovina Therapeutics Inc?
Jeffrey Bacha is the Senior Officer of Rakovina Therapeutics Inc. Other key executives at Rakovina Therapeutics Inc include Senior Officer Mads Daugaard , Director & Senior Officer Alfredo De Lucrezia , and Senior Officer David Hyman .
Rakovina Therapeutics Inc (TSXV:RKV) Insider Trades Summary
Over the past 18 months, Jeffrey Bacha made 3 insider transaction in Rakovina Therapeutics Inc (TSXV:RKV) with a net purchase of 145,000. Other recent insider transactions involving Rakovina Therapeutics Inc (TSXV:RKV) include a net purchase of 107,143 shares made by Alfredo De Lucrezia , a net purchase of 25,000 shares made by Mads Daugaard ,
In summary, during the past 3 months, insiders sold 0 shares of Rakovina Therapeutics Inc (TSXV:RKV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rakovina Therapeutics Inc (TSXV:RKV) were sold and 277,143 shares were bought by its insiders, resulting in a net purchase of 277,143 shares.
Rakovina Therapeutics Inc (TSXV:RKV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rakovina Therapeutics Inc Insider Transactions
Jeffrey Bacha Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey Bacha. Currently GuruFocus does not have mailing address information for Jeffrey Bacha.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
